← Leaderboards
David T Beattie
Avant Immunotherapeutics, Inc.
$218,442
Attributed
$218,442
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$218,442 · 1
By mechanism
R43$218,442 · 1
Top collaborators
No co-investigators on record.
Most similar at Avant Immunotherapeutics, Inc.
Same institution · by research overlap
- Sims K Kochi$870,511
Others in their field
Top investigators on “Attenuated Microorganism”
- Myron Max Levine · University Of Maryland Baltimore$35,871,394
- Sergio Daniel Catz · Scripps Research Institute$18,302,125
- Philip Louis Felgner · Gene Therapy Systems, Inc.$7,354,776
- Bali Pulendran · Stanford University$5,855,594
- William Robert Jacobs · Albert Einstein College Of Medicine$5,683,365
- Clarence J. Peters · University Of Texas Medical Br Galveston$5,653,143
Research focus
Attenuated MicroorganismHerpes Simplex Virus 2Herpesviridae VaccineLaboratory MouseVaccine DevelopmentVector VaccineVirus DnaVirus GeneticsVirus ProteinVirus Replication